Trametinib FDA approval date

The FDA approved Trametinib (Mekinist) on 29 May 2013.

FDA approval date
29 May 2013

Drug identity checked against registry records

Also recorded as Mekinist

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)NCT06346067ERASPhase 3Active not recruiting2028-04Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2013-05-29DayTrametinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA204114", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["MEKINIST"], "active_ingredients": ["TRAMETINIB DIMETHYL SULFOXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20130529", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026